Latest Insider Transactions at Aurinia Pharmaceuticals Inc. (AUPH)
This section provides a real-time view of insider transactions for Aurinia Pharmaceuticals Inc. (AUPH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Aurinia Pharmaceuticals Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Aurinia Pharmaceuticals Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 06
2024
|
Scott Michael Habig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
18,249
-3.85%
|
$91,245
$5.31 P/Share
|
|
May 21
2024
|
Brinda Balakrishnan Director |
SELL
Open market or private sale
|
Direct |
520
-2.88%
|
$2,600
$5.74 P/Share
|
|
May 21
2024
|
Jill Leversage Director |
SELL
Open market or private sale
|
Direct |
5,610
-30.28%
|
$28,050
$5.74 P/Share
|
|
May 21
2024
|
David R.W. Jayne Director |
SELL
Open market or private sale
|
Direct |
4,946
-10.03%
|
$24,730
$5.74 P/Share
|
|
May 21
2024
|
Daniel Billen Director |
SELL
Open market or private sale
|
Direct |
5,252
-15.73%
|
$26,260
$5.74 P/Share
|
|
May 21
2024
|
R. Hector Mac Kay Dunn |
SELL
Open market or private sale
|
Direct |
5,630
-23.24%
|
$28,150
$5.74 P/Share
|
|
Mar 06
2024
|
Joseph M Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
34,811
-6.56%
|
$174,055
$5.6 P/Share
|
|
Mar 06
2024
|
Peter Greenleaf Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
126,981
-7.7%
|
$634,905
$5.6 P/Share
|
|
Mar 06
2024
|
Stephen P. Robertson EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
57,745
-11.51%
|
$288,725
$5.6 P/Share
|
|
Mar 06
2024
|
Scott Michael Habig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,777
-3.61%
|
$88,885
$5.6 P/Share
|
|
Mar 06
2024
|
Matthew Maxwell Donley EVP, Ops & Strategy |
SELL
Open market or private sale
|
Direct |
40,665
-6.51%
|
$203,325
$5.51 P/Share
|
|
Feb 27
2024
|
Volker Knappertz EVP, Research and Development |
SELL
Open market or private sale
|
Direct |
4,930
-1.52%
|
$29,580
$6.1 P/Share
|
|
Feb 20
2024
|
Volker Knappertz EVP, Research and Development |
SELL
Open market or private sale
|
Direct |
25,146
-7.2%
|
$125,730
$5.48 P/Share
|
|
Feb 20
2024
|
Matthew Maxwell Donley EVP, Ops & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
216,666
+25.75%
|
-
|
|
Feb 20
2024
|
Scott Michael Habig Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
15,867
-3.12%
|
$79,335
$5.48 P/Share
|
|
Feb 20
2024
|
Scott Michael Habig Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
195,512
+27.78%
|
-
|
|
Feb 20
2024
|
Peter Greenleaf Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
661,538
+28.63%
|
-
|
|
Feb 20
2024
|
Joseph M Miller Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
196,153
+26.99%
|
-
|
|
Feb 20
2024
|
Stephen P. Robertson EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
194,230
+27.91%
|
-
|
|
May 23
2023
|
David R.W. Jayne Director |
SELL
Open market or private sale
|
Direct |
8,733
-15.05%
|
$96,063
$11.26 P/Share
|
|
May 23
2023
|
Jill Leversage Director |
SELL
Open market or private sale
|
Direct |
4,815
-20.63%
|
$52,965
$11.26 P/Share
|
|
May 23
2023
|
R. Hector Mac Kay Dunn |
SELL
Open market or private sale
|
Direct |
4,818
-16.59%
|
$52,998
$11.26 P/Share
|
|
May 23
2023
|
Daniel Billen Director |
SELL
Open market or private sale
|
Direct |
4,650
-12.22%
|
$51,150
$11.26 P/Share
|
|
May 19
2023
|
David R.W. Jayne Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,310
+13.82%
|
-
|
|
May 19
2023
|
Brinda Balakrishnan Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,310
+34.04%
|
-
|
|
May 19
2023
|
Jill Leversage Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,310
+28.51%
|
-
|
|
May 19
2023
|
R. Hector Mac Kay Dunn |
BUY
Grant, award, or other acquisition
|
Direct |
9,310
+24.27%
|
-
|
|
May 19
2023
|
Daniel Billen Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,310
+19.66%
|
-
|
|
May 19
2023
|
Joseph P Hagan Director |
SELL
Open market or private sale
|
Direct |
272
-2.22%
|
$2,720
$10.58 P/Share
|
|
May 18
2023
|
David R.W. Jayne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,733
+15.2%
|
-
|
|
May 18
2023
|
Brinda Balakrishnan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,733
+50.0%
|
-
|
|
May 18
2023
|
Jill Leversage Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,733
+38.36%
|
-
|
|
May 18
2023
|
R. Hector Mac Kay Dunn |
BUY
Exercise of conversion of derivative security
|
Direct |
8,733
+30.68%
|
-
|
|
May 18
2023
|
George M Milne Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,733
+9.98%
|
-
|
|
May 18
2023
|
Daniel Billen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,733
+23.31%
|
-
|
|
May 18
2023
|
Joseph P Hagan Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,733
+41.65%
|
-
|
|
Mar 02
2023
|
George M Milne Jr Director |
BUY
Open market or private purchase
|
Direct |
20,000
+22.22%
|
$160,000
$8.91 P/Share
|
|
Mar 02
2023
|
Peter Greenleaf Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
32,750
-3.22%
|
$262,000
$8.94 P/Share
|
|
Mar 02
2023
|
Peter Greenleaf Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
667,407
+39.65%
|
-
|
|
Mar 02
2023
|
Volker Knappertz EVP, Research and Development |
BUY
Grant, award, or other acquisition
|
Direct |
191,462
+35.74%
|
-
|
|
Mar 02
2023
|
Scott Michael Habig Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
170,188
+35.24%
|
-
|
|
Mar 02
2023
|
Michael Robert Martin Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
107,202
+29.26%
|
-
|
|
Mar 02
2023
|
Stephen P. Robertson EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
19,402
-6.01%
|
$155,216
$8.94 P/Share
|
|
Mar 02
2023
|
Stephen P. Robertson EVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
204,810
+38.82%
|
-
|
|
Mar 02
2023
|
Joseph M Miller Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,296
-3.3%
|
$90,368
$8.94 P/Share
|
|
Mar 02
2023
|
Joseph M Miller Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
229,421
+40.11%
|
-
|
|
Mar 02
2023
|
Matthew Maxwell Donley EVP, Ops & Strategy |
BUY
Grant, award, or other acquisition
|
Direct |
271,134
+40.21%
|
-
|
|
Nov 21
2022
|
Matthew Maxwell Donley EVP, Ops & Strategy |
BUY
Open market or private purchase
|
Direct |
10,000
+26.37%
|
$40,000
$4.66 P/Share
|
|
Nov 09
2022
|
Scott Michael Habig Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$25,000
$5.01 P/Share
|
|
Nov 07
2022
|
Michael Robert Martin Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+25.1%
|
$150,000
$5.16 P/Share
|